MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 147 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $949,580 | +307.8% | 30,050 | +233.9% | 0.02% | +400.0% |
Q2 2023 | $232,830 | +2.0% | 9,000 | -5.3% | 0.00% | -25.0% |
Q1 2023 | $228,190 | +23.2% | 9,500 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $185,250 | +20.3% | 9,500 | +29.3% | 0.00% | 0.0% |
Q3 2022 | $154,000 | +710.5% | 7,350 | +635.0% | 0.00% | – |
Q2 2022 | $19,000 | -56.8% | 1,000 | -50.0% | 0.00% | -100.0% |
Q1 2022 | $44,000 | -45.0% | 2,000 | -60.0% | 0.00% | 0.0% |
Q4 2021 | $80,000 | -23.8% | 5,000 | -4.8% | 0.00% | -50.0% |
Q3 2021 | $105,000 | +101.9% | 5,250 | +75.0% | 0.00% | +100.0% |
Q2 2021 | $52,000 | +18.2% | 3,000 | +20.0% | 0.00% | 0.0% |
Q4 2020 | $44,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 1,921,118 | $38,269,000 | 6.42% |
FRAZIER MANAGEMENT LLC | 3,566,912 | $71,053,000 | 5.68% |
Novo Holdings A/S | 2,445,147 | $48,707,000 | 2.52% |
Sio Capital Management, LLC | 248,978 | $4,960,000 | 1.58% |
Mesirow Financial Investment Management, Inc. | 25,795 | $514,000 | 1.51% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,282,912 | $65,396,000 | 1.28% |
NEA Management Company, LLC | 4,187,801 | $83,421,000 | 0.99% |
MPM BioImpact LLC | 308,532 | $6,146,000 | 0.95% |
Rock Springs Capital Management LP | 1,525,623 | $30,390,000 | 0.64% |
BVF INC/IL | 435,936 | $8,684,000 | 0.34% |